Returning Incidental Research Findings From 18 F ‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis
Arthritis Care & Research · 2024-12 · 76 (12) · 1637-1646
DOI: 10.1002/acr.25424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 15.10.2024. Verfasst von Jane S Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Medical Center, New York, New York. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Incidental Findings, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Objective
There are limited data on researchers’ attitudes and beliefs on returning and managing incidental research findings from whole body 18 F‐fluorodeoxyglucose–positron emission tomography/computed tomography (FDG PET/CT) imaging.
Methods
Site principal investigators (PIs) who enrolled participants for the Treatments Against Rheumatoid Arthritis and Effect on FDG PET/CT (TARGET) trial were surveyed.
Results
Of the 28 TARGET site PIs eligible for the study, 18 consented to participate (response rate: 64%). Many site PIs returned incidental findings to participants (61%), and the most common finding that was returned was serious (but not life‐threatening) and treatable (54.5%). More than half of the investigators believed that adequacy of clinical follow up (58.8%) and legal liability if incidental findings are not disclosed (55.6%) were extremely important factors in returning incidental research findings from whole body FDG PET/CT. All investigators felt very obligated to return incidental research findings if scans revealed a treatable, high‐risk medical condition. Most investigators felt very obligated to disclose incidental findings with important health implications (94.4%), for which proven preventive or therapeutic interventions exist (77.8%), that provide early detection of a health problem (72.2%), if participants ask for their incidental findings (72.2%), and if scans have established validity for a particular medical condition (61.1%).
Conclusion
Although it is recommended that researchers report and manage incidental research findings, our data show differing views and uncertainties on what and how to return, and the extent of follow up needed to manage, incidental findings from whole body FDG PET/CT; this highlights the need for more specific and standardized guidance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Columbia University Medical Center, New York, New York.
- Cedars-Sinai Medical Center, Los Angeles, California.
- Brigham and Women's Hospital, Boston, Massachusetts.
ORCID-Profile: Jane S Kang, Jon T Giles, Katherine P Liao, Daniel H Solomon, Joan M Bathon
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Kang, J. S., Andrews, H. F., Giles, J. T., Liao, K. P., Solomon, D. H., & Bathon, J. M. (2024). Returning Incidental Research Findings From 18 F ‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis. Arthritis Care & Research, 76(12), 1637-1646. https://doi.org/10.1002/acr.25424
Vancouver
Kang JS, Andrews HF, Giles JT, Liao KP, Solomon DH, Bathon JM. Returning Incidental Research Findings From 18 F ‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis. Arthritis Care & Research. 2024;76(12):1637-1646. doi:10.1002/acr.25424
BibTeX
@article{Kang2024,
author = {Kang, Jane S and Andrews, Howard F and Giles, Jon T and Liao, Katherine P and Solomon, Daniel H and Bathon, Joan M},
title = {Returning Incidental Research Findings From 18 F ‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis},
journal = {Arthritis Care & Research},
year = {2024},
volume = {76},
number = {12},
pages = {1637--1646},
doi = {10.1002/acr.25424}
}
EUVIMED